{"id":407203,"date":"2021-01-04T06:03:33","date_gmt":"2021-01-04T11:03:33","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=407203"},"modified":"2021-01-04T06:03:33","modified_gmt":"2021-01-04T11:03:33","slug":"ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/","title":{"rendered":"IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">SOUTH SAN FRANCISCO<\/span><br \/>\n        <b>, <\/b>Calif., <span class=\"xn-chron\">Jan. 4, 2021<\/span> \/PRNewswire\/ &#8212; IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced its participation at the following upcoming investor relations events and scientific conferences.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg\" title=\"(PRNewsfoto\/IDEAYA Biosciences, Inc.)\" alt=\"(PRNewsfoto\/IDEAYA Biosciences, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <u>Investor Relations Events<\/u>\n      <\/p>\n<ul type=\"disc\">\n<li>JP Morgan 39<sup>th<\/sup> Annual Healthcare Conference 2021 (Virtual)<br \/>Company Presentation<br \/><span class=\"xn-chron\">Wednesday, January 13<\/span><sup>th<\/sup>, 2021 at <span class=\"xn-chron\">5:20 pm ET<\/span><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>HC Wainwright Bioconnect (Virtual)<br \/>Company Presentation<br \/><span class=\"xn-chron\">Thursday, January 14<\/span><sup>th<\/sup>, 2021, at <span class=\"xn-chron\">6:00 am ET<\/span><\/li>\n<\/ul>\n<p>A live audio webcast of each presentation will be available by visiting the &#8220;Investors\/News and Events\/Investor Calendar&#8221; section of the IDEAYA website at\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3024757-1&amp;h=372917052&amp;u=https%3A%2F%2Fir.ideayabio.com%2Fnews-events%2Finvestor-calendar&amp;a=https%3A%2F%2Fir.ideayabio.com%2Fnews-events%2Finvestor-calendar\" rel=\"nofollow noopener noreferrer\">https:\/\/ir.ideayabio.com\/news-events\/investor-calendar<\/a>.\u00a0A replay of the webcasts will be available for 30 days following the live event.<\/p>\n<p>\n        <u>Scientific Conferences<\/u>\n      <\/p>\n<ul type=\"disc\">\n<li>PARP &amp; DDR Inhibitors Summit 2021 (Digital)<br \/>Presentation Session \u2013 Next Generation Synthetic Lethal Interactions<br \/>&#8220;<i>Pharmacological inhibition of DNA polymerase theta (Polq) activity shows promise as novel treatment for homologous recombination deficient tumors<\/i>&#8221; <br \/><span class=\"xn-chron\">Thursday, January 28<\/span><sup>th<\/sup>, 2021 at <span class=\"xn-chron\">2:15 pm ET<\/span><\/li>\n<\/ul>\n<p>The PARP &amp; DDR Inhibitors Summit will be held <span class=\"xn-chron\">January 26<\/span><sup>th<\/sup>-28<sup>th<\/sup>, 2021.\u00a0<i>See <\/i><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3024757-1&amp;h=2696571500&amp;u=http%3A%2F%2Fparp-ddr-inhibitors-summit.com%2Fabout%2Fthe-summit%2F&amp;a=http%3A%2F%2Fparp-ddr-inhibitors-summit.com%2Fabout%2Fthe-summit%2F\" rel=\"nofollow noopener noreferrer\">http:\/\/parp-ddr-inhibitors-summit.com\/about\/the-summit\/<\/a>.<\/p>\n<p>\n        <b>About IDEAYA Biosciences<\/b>\n      <\/p>\n<p>IDEAYA is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.\u00a0 IDEAYA&#8217;s approach integrates capabilities in identifying and validating translational biomarkers with small molecule drug discovery to select patient populations most likely to benefit from the targeted therapies IDEAYA is developing.\u00a0IDEAYA is applying these capabilities across multiple classes of precision medicine, including synthetic lethality \u2013 which represents an emerging class of precision medicine targets.\u00a0 <\/p>\n<p>\n        <b>Forward-Looking Statements<\/b>\n      <\/p>\n<p>This press release contains forward-looking statements, including, but not limited to, statements related to participation in and\/or presentation at certain investor relations events and scientific conferences. IDEAYA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of IDEAYA in general, see IDEAYA&#8217;s recent Quarterly Report on Form 10-Q filed on <span class=\"xn-chron\">November 12, 2020<\/span> and any current and periodic reports filed with the U.S. Securities and Exchange Commission.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=AQ36035&amp;sd=2021-01-04\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences-301199949.html\">http:\/\/www.prnewswire.com\/news-releases\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences-301199949.html<\/a><\/p>\n<p>SOURCE  IDEAYA Biosciences, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=AQ36035&amp;Transmission_Id=202101040600PR_NEWS_USPR_____AQ36035&amp;DateId=20210104\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SOUTH SAN FRANCISCO , Calif., Jan. 4, 2021 \/PRNewswire\/ &#8212; IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced its participation at the following upcoming investor relations events and scientific conferences. Investor Relations Events JP Morgan 39th Annual Healthcare Conference 2021 (Virtual)Company PresentationWednesday, January 13th, 2021 at 5:20 pm ET HC Wainwright Bioconnect (Virtual)Company PresentationThursday, January 14th, 2021, at 6:00 am ET A live audio webcast of each presentation will be available by visiting the &#8220;Investors\/News and Events\/Investor Calendar&#8221; section of the IDEAYA website at\u00a0https:\/\/ir.ideayabio.com\/news-events\/investor-calendar.\u00a0A replay of the webcasts will be available for 30 days following the live event. Scientific Conferences PARP &amp; DDR Inhibitors &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-407203","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SOUTH SAN FRANCISCO , Calif., Jan. 4, 2021 \/PRNewswire\/ &#8212; IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced its participation at the following upcoming investor relations events and scientific conferences. Investor Relations Events JP Morgan 39th Annual Healthcare Conference 2021 (Virtual)Company PresentationWednesday, January 13th, 2021 at 5:20 pm ET HC Wainwright Bioconnect (Virtual)Company PresentationThursday, January 14th, 2021, at 6:00 am ET A live audio webcast of each presentation will be available by visiting the &#8220;Investors\/News and Events\/Investor Calendar&#8221; section of the IDEAYA website at\u00a0https:\/\/ir.ideayabio.com\/news-events\/investor-calendar.\u00a0A replay of the webcasts will be available for 30 days following the live event. Scientific Conferences PARP &amp; DDR Inhibitors &hellip; Continue reading &quot;IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-04T11:03:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences\",\"datePublished\":\"2021-01-04T11:03:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\\\/\"},\"wordCount\":386,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/820568\\\/IDEAYA_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\\\/\",\"name\":\"IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/820568\\\/IDEAYA_Logo.jpg\",\"datePublished\":\"2021-01-04T11:03:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/820568\\\/IDEAYA_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/820568\\\/IDEAYA_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/","og_locale":"en_US","og_type":"article","og_title":"IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences - Market Newsdesk","og_description":"PR Newswire SOUTH SAN FRANCISCO , Calif., Jan. 4, 2021 \/PRNewswire\/ &#8212; IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced its participation at the following upcoming investor relations events and scientific conferences. Investor Relations Events JP Morgan 39th Annual Healthcare Conference 2021 (Virtual)Company PresentationWednesday, January 13th, 2021 at 5:20 pm ET HC Wainwright Bioconnect (Virtual)Company PresentationThursday, January 14th, 2021, at 6:00 am ET A live audio webcast of each presentation will be available by visiting the &#8220;Investors\/News and Events\/Investor Calendar&#8221; section of the IDEAYA website at\u00a0https:\/\/ir.ideayabio.com\/news-events\/investor-calendar.\u00a0A replay of the webcasts will be available for 30 days following the live event. Scientific Conferences PARP &amp; DDR Inhibitors &hellip; Continue reading \"IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-04T11:03:33+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences","datePublished":"2021-01-04T11:03:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/"},"wordCount":386,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/","name":"IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg","datePublished":"2021-01-04T11:03:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-january-2021-investor-relations-events-and-scientific-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IDEAYA to Participate in Upcoming January 2021 Investor Relations Events and Scientific Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=407203"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407203\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=407203"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=407203"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=407203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}